glp 1 agonists addiction GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives IUPHAR review – Glucagon-like peptide-1

Liraglutide offers an affordable GLP-1 option for managing antipsychotic weight gain.

FDA is requesting that the risk be removed from the warnings and precautions section of labeling for the GLP-1 obesity drugs Eli Lilly and Co.s Zepbound (tirzepatide) and Novo Nordisk A/S Saxenda (liraglutide) and Wegovy (semaglutide).

hazard ratio 1.60, 95% CI 1.37 to 1.87) but not after confounding factors were accounted for (0.91, 0.73 to 1.12)

You may have been reading a lot about newly launched obesity drugs and I covered some of this in my podcast last year with Stephan Guyenet in anticipation

It is not a direct measure of skeletal muscle